AE
Highly rated in
61
conditions
Highly rated in
61
conditions
Check Dr. Alberto J. Espay's experience treating your condition:
About Dr. Alberto J. Espay

Alberto Espay is a Neurologist in Cincinnati, Ohio. Espay has been practicing medicine for over 28 years and is highly rated in 61 conditions, according to our data. His top areas of expertise are Parkinson's Disease, Drug Induced Dyskinesia, Herpes Zoster Oticus, Focal Dystonia, and Deep Brain Stimulation. He is licensed to treat patients in Ohio. Espay is currently accepting new patients.

His clinical research consists of co-authoring 331 peer reviewed articles and participating in 10 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Alberto J. Espay it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Dr. Alberto J. Espay accepts the following insurance:

  •  Ambetter
  •  Anthem
  •  Molina Healthcare
  •  CareSource
  •  Buckeye Health

Call to see if your plan is accepted.
Locations
3113 Bellevue Ave, Cincinnati, OH 45219
Background & Education
Graduate Institution
Other, 1994
Specialties
Neurology
Licenses
Psychiatry & Neurology in OH
Hospital Affiliations
Mercy Health - Anderson Hospital
Daniel Drake Center
University Of Cincinnati Medical Center
Languages Spoken
English
Spanish
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


9 Clinical Trials

Study in Parkinson Disease of Exercise Phase 3 Clinical Trial: SPARX3
The Parkinson's Progression Markers Initiative (PPMI)
OnabotulinumtoxinA in the Management of Psychogenic Dystonia
Botulinum Toxin Type A (Botox) in the Management of Levodopa-Induced Peak-Dose Dyskinesias in Parkinson's Disease: A Double-Blind, Randomized, Placebo Controlled, Cross-Over Design Study
Methylphenidate for the Treatment of Gain Impairment in Parkinson's Disease: a Randomized Double-Blind, Placebo-Controlled, Cross-over Study
View 7 Less Clinical Trials -

Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors